Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 46INDUSTRY 10UNKNOWN 6OTHER_GOV 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Cancer 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × titanium silicide × Clear all
NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
47 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 1/2 Unknown
74 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00512681 2009-09-18

TIROX2

National Cancer Center, Korea

Phase 2 Completed
44 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡